Monofunctional platinum amine complexes destabilize DNA significantly

European Journal of Biochemistry

Volumn 256, Issue 2, 1998, Pages 253-260

  Bauer, Cornelia ^a   Peleg Shulman, Tal ^b   Gibson, Dan ^b,c   Wang, Andrew H J ^a,d  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d Dept of Cell and Structural Biology ^*  (United States)

Author keywords

Anti cancer; Cisplatin; DNA; Methylpyridine; NMR

Indexed keywords

DOUBLE STRANDED DNA; PLATINUM DERIVATIVE;

ARTICLE; CIS ISOMER; DNA BINDING; DNA STRUCTURE; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; TRANS ISOMER;

EID: 0031718788     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1998.2560253.x     Document Type: Article

References (43)

1. Rosenberg, B., Van Camp, L. & Kirgan, T. (1965) Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode, Nature 205, 698-699.
2. Comess, K. M. & Lippard, S. J. (1993) Molecular aspects of platinum-DNA interactions, in Molecular aspects of anticancer drug - DNA interactions, (Neidle, S. & Waring, M., eds) vol. 1, pp. 134-168, Macmillan, London.
3. Roberts, J. J. (1981) The mechanism of action of anti tumour platinum coordination compounds, Adv. Inorg. Biochem. 3, 274-332.
4. Cleare, M. J. & Hydes, P. C. (1980) Antitumor properties of metal complexes, Met. Ions Biol. Syst. 11, 1-62.
5. Reedijk, J. (1992) The relevance of hydrogen bonding in the mechanism of action of platinum antitumor compounds, Inorg. Chim. Acta 198-200, 873-881.
6. Pinto, A. L. & Lippard, S. J. (1985) Binding of the antitumor drug cis-diamminedichloroplatinum(II) (Cisplatin) to DNA, Biochem. Biophys. Acta 780, 167-180.
7. 2 and its adduct with the anticancer drug cis-diamminedichloroplatinum(II), Inorg. Chem. 27, 1454-1466.
8. Lippert, B. (1996) Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids, Met. Ions Biol. Syst 33, 105-141.
9. Yang, D., van Boom, S. S. G. E., Reedijk, J., van Boom, J. H. & Wang, A. H.-J. (1995) Structure and isomerization of an intrastrand cisplatin-cross-linked octamer DNA duplex by NMR analysis, Biochemistry 34, 12912-12920.
10. Fichtinger-Schepman, A. M., van der Veer, J. L., den Hartog, J. H. J., Lohman, P. H. M. & Reedijk, J. (1985) Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. Biochemistry 24, 707-713.
11. Sip, M., Schwartz, A., Vovelle, F., Ptak, M. & Leng, M. (1992) Distortions induced in DNA by cisplatin interstrand adducts, Biochemistry 31, 2508-2513.
12. Schwartz, A. & Leng, M. (1994) Dnase I footprinting of cis- or trans-diamminedichloroplatinum(II)-modified DNA, J. Mol. Biol. 236, 969-974.
13. Takahara, P. M., Rosenzweig, A. C., Frederick, C. A. & Lippard, S. J. (1995) Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin, Nature 377, 649-652.
14. Pil, P. M. & Lippard, S. J. (1992) Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin, Science 256, 234-237.
15. Yang, D., van Boom, S. S. G. E., Reedijk, J., van Boom, J. H., Farrell, N. & Wang, A. H.-J. (1995) A novel DNA structure induced by the anticancer bisplatinum compound crosslinked to a GpC site in DNA, Nat. Struct. Biol. 2, 577-586.
16. Yang, D. & Wang, A. H.-J. (1996) Structural studies of interactions between anticancer platinum drugs and DNA, Prog. Biophys. Mol. Biol. 66, 81-111.
17. Brown, S. J., Kellert, P. J. & Lippard, S. J. (1993) Ixr1, a yeast protein that binds to platinated DNA and confers sensitivity to cisplatin, Science 261, 603-605.
18. McKeage, M. J. & Kelland, L. R. (1993) New platinum drugs, in Molecular aspects of anticancer drug-DNA interactions (Neidle, S. & Waring, M., eds) vol. 1, pp. 169-212, Macmillan, London.
19. Cleare, M. J. & Hoeschele, J. D. (1973) Studies on the antitumor activity of group VIII transition metal complexes. Part I. Platinum(II) complexes, Bioinorg. Chem. 2, 187.
20. Calvert, A. H. (1986) Clinical applications of platinum metal complexes, in Biochemical mechanisms of platinum antitumor drugs (McBrien, D. C. H. & Slater, T. F., eds) pp. 307-328, IRI Press, Washington, DC.
21. Hoeschele, J. D., Kraker, A. J., Qu, Y., Van Houten, B. & Farrell, N. (1990) Bis(platinum) complexes, chemistry, antitumor activity and DNA-binding, in Molecular basis of specificity in nucleic acid-drug interactions (Pullman, B. & Jortner, J., eds) pp. 301-321, Kluwer, Dordrecht.
22. +, J. Med. Chem. 32, 128-136.
23. Macquet, J. P. & Butour, J.-L. (1983) Platinum-amine compounds: importance of the labile and inert ligands for their pharmacological activities toward L1210 leukemia cells, J. Natl Cancer Inst. 70, 899-905.
24. Hollis, L. S., Sundquist, W. L. Burstyn, J. N., Heiger-Bernays, W. J., Bellon, S. F., Ahmed, K. J., Amundsen, A. R., Stern, E. W. & Lippard, S. J. (1991) Mechanistic studies of a novel class of tri-substituted platinum(II) antitumor agents, Cancer Res. 51, 1866-1875.
25. Fastman, G. D. (ed.) (1975) Handbook of biochemistry and molecular biology: nucleic acids, 3rd edn, vol. 1, CRC Press, Cleveland.
26. Robinson, H. & Wang, A. H.-J. (1992) A simple spectral-driven procedure for the refinement of DNA structures by NMR spectroscopy, Biochemistry 31, 3524-3533.
27. Robinson, H. & Wang, A. H.-J. (1993) 5′-CGA sequence is a strong motif for homo base-paired parallel-stranded DNA duplex as revealed by NMR analysis. Proc. Natl Acad. Sci. USA 90, 5224-5228.
28. States, D. J., Haberkorn, R. A. & Ruben, D. J. (1982) A two-dimensional nuclear Overhauser experiment with pure absorption phase in four quadrants, J. Magn. Reson. 48, 286-292.
29. Hore, P. J. (1983) A new method for water suppression in the proton NMR spectra of aqueous solutions, J. Magn. Reson. 54, 539-542.
30. Sklenar, V., Brooks, B. R., Zon, G. & Bax, A. (1987) Absorption mode two-dimensional NOE spectroscopy of exchangeable protons in oligonucleotides, FEBS Lett. 216, 249-252.
31. Sklenar, V., Tschudin, R. & Bax, A. (1987) Water suppression using a combination of hard and soft pulses, J. Magn. Reson. 75, 352-357.
32. Marion, D., Ikura, M. & Bax, A. (1989) Improved solvent suppression in one- and two-dimensional NMR spectra by convolution of time-domain data, J. Magn. Reson. 84, 425-430.
33. Brünger, A. T. (1992) X-PLOR, version 3.1, a system for X-ray crystallography, Yale University Press, New Haven, Conn.
34. Keeper, J. W. & James, T. L. (1984) A theoretical study of distance determinations from NMR two-dimensional nuclear Overhauser effect spectra, J. Magn. Reson. 57, 404-426.
35. Hare, D., Wemmer, D. E., Chou, S. H., Drobny, G. & Reid, B. R. (1983) Assignment of the non-exchangeable proton resonances of d(C-G-C-G-A-A-T-T-C-G-C-G) Using two-dimensional nuclear magnetic resonance methods, J. Mol. Biol. 171, 319-336.
36. Dalbiès, R., Boudvullain, M. & Leng, M. (1996) Trans-diamminedichloroplatinum(II) is not an antitumor drug: why?, in Platinum and other metal coordination compounds in cancer chemotherapy (Pinedo, H. M. & Schornagel, J. H., eds) vol. 2, pp. 17-25, Plenum, London.
37. Farrell, N. (1993) Nonclassical platinum antitumor agents: perspectives for design and development of new drugs complementary to cisplatin, Cancer Invest. 11, 578-589.
38. Perez, C., Leng, M. & Malinge, J. M. (1997) Rearrangement of interstrand cross-links into intrastrand cross-links in cis-diamminedichloroplatinum(II)-modified DNA. Nucleic Acids Res. 25, 896-903.
39. 2+-modified DNA: rates of cross-linking reactions in cis-platinum-modified DNA, Nucleic Acids Res. 21, 5846-5851.
40. Lippard, S. J. (1987) Chemistry and molecular biology of platinum anticancer drugs, Pure Appl. Chem. 59, 731-742.
41. Zwelling, L. A., Anderson, T. & Kohn, K. W. (1979) DNA-protein and DNA interstrand cross-linking by cis- and trans-platinum(II)-diamminedichloride in L1210 mouse leukemia cells and relation to cytotoxicity. Cancer Res. 39, 365-369.
42. 3, pyridine), Biochemistry 32, 9632-9638.
43. Farrell, N., Kelland, L. R., Roberts, J. D. & van Beusichem, M. (1992) Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human minor panels and studies on their mechanism of action, Cancer Res. 52, 5065-5072.